Quality Assessment of Diagnostic Methods Employed for Suspected Lung Cancer

被引:0
作者
Verma, Akash [1 ]
Phua, Chee K. [1 ]
Sim, Wen Y. [1 ]
Lim, Albert Y. H. [1 ]
Tai, Dessmon Y. H. [1 ]
Goh, Soon K. [1 ]
Kor, Ai C. [1 ]
Ho, Benjamin [1 ]
Abisheganaden, John [1 ]
机构
[1] Tan Tock Seng Hosp, Dept Resp & Crit Care Med, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore
关键词
Bronchoscopy; quality; lung cancer; TTNA; EBUS-TBNA;
D O I
10.2174/1573398X12666160301231630
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: In diagnosing lung cancer, evidence-based guidelines recommend choosing the procedure that is safe, least invasive, and provides information about stage of the cancer together with the diagnosis. This study was done to assess the quality of practice patterns for diagnosing lung cancer. Methods: Retrospective review of patients diagnosed with lung cancer from January 2011 - December 2013. Results: Intra-parenchymal mass & mediastinal abnormality (discrete lymph node and mediastinal infiltration) were the common intra-thoracic radiological abnormality seen in 80 (64.5%) and 71 (57.2%) of patients respectively. TTNA was the most commonly performed procedure. No radiological difference in size & location of the mass was found in TTNA or bronchoscopy group. The yield of TTNA was higher than bronchoscopy (95% vs 68%, p=0.001) and the cost per patient was lower (S$ 581 vs S$ 1122, p= 0.001). However TTNA correlated with missed opportunity of nodal staging in (52.5%) of patients, greater complication rate (48%), and delayed diagnosis by 14 (1-337) days. In bronchoscopy, the delay was shorter, and complication rate was lower. However 72.7% of patients missed opportunity of nodal staging, and the number of procedures needed per patient for diagnosis was higher (1.34 vs 1.05, p= 0.02). Conclusion: Bronchoscopy was timely and safer technique than TTNA, but fraught with need for repeat procedures, and higher cost. TTNA on the other hand was more diagnostic and inexpensive than bronchoscopy but had high rate of complication, and delayed diagnosis. Both procedures had high rate of discordance with the guidelines & missed information regarding stage. Reserving TTNA for small peripheral lesions without mediastinal abnormality or bronchus sign, greater adoption of convex probe EBUS-TBNA, and availability of daily TTNA were the factors identified to improve quality.
引用
收藏
页码:175 / 182
页数:8
相关论文
共 23 条
[1]   Diagnostic yield of fiberoptic bronchoscopy in evaluating solitary pulmonary nodules [J].
Baaklini, WA ;
Reinoso, MA ;
Gorin, AB ;
Sharafkanch, A ;
Manian, P .
CHEST, 2000, 117 (04) :1049-1054
[2]  
Campbell Robert James, THINKING LEAN HEALTH
[3]  
Committee on Quality of Health Care in America Institute of Medicine, 2001, CROSSING QUALITY CHA
[4]   Systemic air embolism during percutaneous core needle biopsy of the lung: frequency and risk factors [J].
Freund, Martin C. ;
Petersen, Johannes ;
Goder, Katharina C. ;
Bunse, Tillmann ;
Wiedermann, Franz ;
Glodny, Bernhard .
BMC PULMONARY MEDICINE, 2012, 12
[5]   Endobronchial ultrasound-guided transbronchial needle aspiration for staging of lung cancer: A systematic review and meta-analysis [J].
Gu, Ping ;
Zhao, Yi-Zhuo ;
Jiang, Li-Yan ;
Zhang, Wei ;
Xin, Yu ;
Han, Bao-Hui .
EUROPEAN JOURNAL OF CANCER, 2009, 45 (08) :1389-1396
[6]   Time intervals from first symptom to treatment of cancer: a cohort study of 2,212 newly diagnosed cancer patients [J].
Hansen, Rikke P. ;
Vedsted, Peter ;
Sokolowski, Ineta ;
Sondergaard, Jens ;
Olesen, Frede .
BMC HEALTH SERVICES RESEARCH, 2011, 11
[7]   National comparisons of lung cancer survival in England, Norway and Sweden 2001-2004: differences occur early in follow-up [J].
Holmberg, Lars ;
Sandin, Fredrik ;
Bray, Freddie ;
Richards, Mike ;
Spicer, James ;
Lambe, Mats ;
Klint, Asa ;
Peake, Mick ;
Strand, Trond-Eirik ;
Linklater, Karen ;
Robinson, David ;
Moller, Henrik .
THORAX, 2010, 65 (05) :436-441
[8]  
Leatherman Sheila, 2004, BMJ, V328, pE288, DOI 10.1136/bmj.328.7445.E288
[9]  
National Institute for Health and Clinical Excellence, DIAGN TREATM LUNG CA
[10]  
NHS Information Centre. National Lung Cancer Audit, 2010, NAT LUNG CANC AUD 20